Related Experiment Video
Updated: Oct 23, 2026

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins
Published on: August 7, 2014
[Binding of various polycyclic aromatic hydrocarbons (PAH) by plasma albumin and blood cells]
M Lipniak1, J Brandys, A Moniczewski
1Z Katedry Toksykologii, Akademii Medycznej im. M. Kopernika w Krakowie, Kierownik Katedry.
Abstract:
We have studied in vivo and in vitro partition of pyrene, fluoranthene and benz(a)anthracene (BaA) between blood cells and plasma or phosphate buffer pH 7.4 and their binding to bovine serum albumin. The level of PAH in blood and plasma was determined in rats after i.v. administration of pyrene, fluoranthene and BaA in dose 20 mg/kg by gas chromatography method. In vitro 20 micrograms of PAH was added to blood samples or blood cell suspension. These samples were incubated at 37 degrees C. After 1 hr the concentration of PAH in blood cell and plasma or buffer was determined. The data indicate that whole pyrene and fluoranthene are distributed to blood cells. 39% of BaA in whole blood is present in blood cells and 56.9% in plasma. Plasma protein binding of PAH were determined by gel filtration 0.4 cm3 of PAH-protein solution was given on a Sephadex column. PAH binding parameters were obtained from simple linear regression of Scatchard plots of the data. In a albumin solution (0.4%) the number of binding sites was 2 for BaA, 3 for pyrene and 11 for fluoranthene. The binding constants for BaA, fluoranthene and pyrene were 0.17; 0.71 and 1.11 mol-1 X 10(4), respectively.
More Related Videos
Related Concept Videos
Drug Distribution: Tissue Binding
For...
Drug Distribution: Plasma Protein Binding
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...

